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SUMMARY
Objectives: To describe the main pathophysiological differences in neurosurgical pro-
cedures between children and adults; the main complications and adverse events re-
sulting from pediatric neurosurgery reported in studies; the singularities in anesthetic 
and intraoperative management in several neurosurgical diseases; the more specific and 
common complications and their management in the most frequent pediatric neuro-
surgical procedures, as well as causes and treatment for the main complications found 
in children undergoing neurosurgery. Methods: A non-systematic review in literature 
databases PubMed, EMBASE, and SciELO was performed by using the keywords “pe-
diatrics”, “children”, “neurosurgery”, “risk factors”, “intraoperative complications”, and 
“postoperative period”, as well as their matches in Portuguese and Spanish from January 
2001 to January 2011, in addition to using important references from the selected mate-
rial over any period of time. Results: The three procedures most commonly performed 
in children are hydrocephalus, craniostenosis repair, and brain tumor resection. Com-
plications as fever, bleeding, metabolic disturbances (hyponatremia and hyperglycemia), 
brain swelling, and transient focal deficits (limb weakness, speech and swallowing dis-
orders) are frequent but their course is often towards prompt improvement. Up to 50% 
of children may have an uneventful evolution over the postoperative period. Special at-
tention must be given to the prevention of postoperative infections and seizures with the 
use of a drug therapy that suits each case. Conclusion: The complexity of neurosurgical 
procedures in children is increasing, and observation and recognition of complications 
in pediatric intensive care units are fundamental. Anticipating complications in order 
to achieve an early treatment and adverse event prophylaxis can contribute to reduced 
morbidity and mortality and increased patients’ safety.
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INTRODUCTION
The increased complexity and improvement of care and 
monitoring for children undergoing neurosurgical pro-
cedures has been marked over last years. Neurosurgical 
patients are usually complex, and in almost all cases, need 
postoperative monitoring in an intensive care unit. The 
most frequent complications reported in medical litera-
ture are bleeding, seizures, sodium disturbances, and co-
agulation disorders. Case studies find a mean of 40% to 
50% of cases with no postoperative complications1. Most 
patients referred to a pediatric neurosurgeon have already 
obtained a baseline diagnosis. The widespread use of com-
puted tomography (CT) and magnetic resonance imaging 
(MRI) has reduced diagnostic difficulty; consequently, as 
in other surgical specialties, pediatric neurosurgeons often 
see the investigational process inversely from diagnosis2.
In this setting, it is relevant to list a number of impor-
tant characteristics distinguishing procedures performed 
by pediatric surgeons from those performed by adult neu-
rosurgeons. Rekate, in a review article published in 20093, 
discusses the anatomophysiologic particularities of pe-
diatric neurosurgical patients. The types of brain tumors 
treated by pediatric neurosurgeons are different from 
those treated by general neurosurgeons. Craniocerebral 
trauma experimented by children tends to progress with 
less brain mass injury compared with adult trauma. Spi-
nal cord development features in children and congenital 
and inherited diseases of these patients make the decision 
process for how to act during surgical procedures different 
from the process in adults. Congenital defects in central 
nervous system are seldom corrected by a single surgery 
– indeed, they are usually lifetime challenges. In addition, 
hydrocephalus, which might occur in any age, is much 
more challenging from a clinical and surgical prospective, 
when its onset is in infancy or childhood. These conditions 
stress the unique surgical challenges for the pediatric age 
group these patients face.
With increasing demand and complexity of neurosur-
gical patients over the last years and ongoing technological 
advances in the area, there is an increased need to devel-
op measures to improve care and assure uniform patient 
management. Technological and therapeutic advances 
have increased over the last decades, including alteplase 
use in ischemic stroke, hypothermia for neuroprotection 
after a cardiac arrest, improvement in monitoring cranio-
cerebral trauma, and use of devices for intravascular cool-
ing in cases of intracranial bleeding4.
Thus, the need for knowledge of the major adverse 
events in children undergoing neurosurgery is increasing-
ly important in the development of preventive measures 
and prompt treatment, in order to reduce the morbidity 
and mortality associated with these procedures. This re-
view aims to:
t Describe the main surgical management of neuro-
logical diseases during childhood and present the 
causes and management of major complications, 
general and specific, of the more frequent proce-
dures in children undergoing neurosurgery, ac-
cording to the latest publications
t Describe the recommendations for prophylaxis of 
infections and seizures in the postoperative period
t List and discuss the most common general compli-
cations in pediatric neurosurgical patients, as well 
as submit proposals for each specific therapeutic 
complication.
SURVEILLANCE OF ADVERSE EVENTS AND MORTALITY IN 
PEDIATRIC NEUROSURGERY
In pediatric neurosurgery, the assessment of adverse 
events and risk factors of morbidity and mortality is rare, 
and little is known about the complications of surgical 
events. Children undergoing neurosurgical procedures 
may presumably have more complications when com-
pared to adults. Factors such as need for emergency pro-
cedures, severe associated comorbidities (such as prema-
turity), and other complications inherent to the age group 
as communication difficulties, sedation, and intravenous 
access can significantly increase morbidity and mortality 
in these patients. 
The risks and complications associated with anesthesia 
can be divided into minor or serious. Minor risks include 
inflammation of the oropharynx, nausea and vomiting, 
laryngitis, and mild lesions of the oral cavity, which are 
frequent but present low morbidity and short duration. 
More serious complications include dental fractures at the 
time of intubation for airway aspiration, aspiration pneu-
monia, postoperative apnea, anaphylaxis, hypoxia, brady-
cardia, and cardiac arrhythmia after anesthetic induction5. 
Factors that may contribute to increased incidence of an-
esthetic complications in children include age; physiologi-
cal, immunological and laboratorial conditions; duration 
of anesthesia and surgery; and urgency of the surgical 
procedure6.
Drake et al.7 studied complications associated with 
1,082 pediatric neurosurgical procedures. Among the 
procedures listed, the most frequent were cerebrospinal 
fluid shunts (38.4%) and brain tumor surgeries (17.5%). 
Overall, complications were described in 16.4% of total 
procedures, a significantly lower rate compared with pre-
vious studies. Among the complications, fistula (17.5%), 
new focal neurologic deficit (15.3%), obstruction shunt 
(15.3%), infected shunt (13.6%), postoperative bleeding 
(6.8%), wound infection (5.6%), postoperative bleeding 
(5.1%), and pneumonia or respiratory complications (4%) 
were reported.
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Time zero
Preintubation history 
anamnesis
Identify risk factors for 
 high ICP
Preoxygenation
Venous line attainment
Equipment and staff 
veriﬁcation
Medication preparation
Maintain preoxygenation
Premedication
Cricoid compression
Lidocaine 1 mg/kg
(minimum infusion time – 
1 minute)
Sedation
Thiopental 3-5 mg/kg
Options:
Midazolam 0.2-0.4 mg/kg
Etomidate 0.4 mg/kg
Neuromuscular blockade
Rocuronium 0.6-1 mg/kg
Intubation
0-3 minutes
3-5 minutes
5-6 minutes
Figure 1 – Flow chart for a rapid sequence intubation in 
patients with high intracranial pressure (ICP).
Aleksic et al.8 retrospectively studied anesthetic com-
plications in 705 children up to 15 years of age undergoing 
elective neurosurgical procedures or after severe cranio-
cerebral trauma. Anesthetic complications occurred in 68 
patients, with 29 of them occurring during induction and 
39 during surgery and anesthesia maintenance. Reported 
complications were bradycardia (2.69%); cardiac arrhyth-
mias (0.71%); other complications, such as spontaneous 
breathing cessation, high blood pressure, air embolism, 
bleeding, bronchospasm, and hypoxemia were observed 
in less than 1% of patients.
ANESTHESIA IN THE PEDIATRIC NEUROSURGERY PATIENT
Every pediatric anesthetic procedure is a challenge for the 
anesthesiologist. It is important to have in mind that chil-
dren are unique from a pathophysiological and psycho-
logical perspective. Moreover, the selection of appropriate 
anesthetic techniques and drugs will positively impact the 
postsurgical outcome, minimizing the risk of future neu-
rological complications and sequelae9.
PREOPERATIVE PREPARATION AND INTRAOPERATIVE MANAGEMENT 
FEATURES
High intracranial pressure (ICP) is one of the main features 
to be assessed prior to surgery, although the emergency 
characteristic of the procedure associated with this condi-
tion frequently may not allow for an appropriate prepara-
tion10. Patients with behavior, speech or eating disorders, 
as well as vomiting not preceded by nausea, lethargy, or ir-
ritability are at risk for high ICP. Older children may com-
plain of headache and double vision. An irregular respira-
tory rate (Cheyne-Stokes) may develop in the presence of 
severe high ICP, as well as a Cushing triad (bradycardia, 
high blood pressure, and irregular respiratory pattern) in 
the presence of uncal herniation. Even in the absence of 
clinical decompensation signs, an intracranial injury with 
mass effect can impair brain parenchyma elasticity, so that 
a small hemodynamic or ventilatory change could cause 
rapid increases in ICP and severe complications.
Preoperative anamnesis is of paramount importance 
and must assess ICP, possible difficulties in orotracheal in-
tubation, and cardiorespiratory conditions which might be 
associated with handling tumors in the posterior cranial 
fossa. Other problems, such as changes in cardiac anatomy 
increasing the risk for thromboembolic events and stroke 
should be identified; anemia and dehydration must be 
promptly corrected. Appropriate monitoring and appara-
tus are key for conducting anesthesia.
Drugs reducing high ICP peaks associated with laryn-
goscopy, as well as reducing the brain metabolic rate so 
that the organ oxygen consumption can be reduced should 
be employed in specific high ICP contexts, such as rapid 
sequence orotracheal intubation. Among drugs, lidocaine 
(1 mg/kg) and thiopental (3-5 mg/kg) use is advocated 
in order to reach targets, as illustrated in Figure 111. An-
other fundamental feature is intraoperative fluid manage-
ment. The anesthesiologist must be aware of volume losses 
over the procedure, particularly in craniostenosis repairs, 
where blood transfusions are almost universally required. 
Hypoosmolar solutions (such as lactated Ringer’s, whose 
osmolality is 273 mOsm/L) must be avoided, in order to 
prevent interstitial edema. Perioperative corticosteroid use 
is controversial, even though they are often used; they can 
have an anti-hypertensive action, reducing brain swell-
ing and consequently ICP. Among authors advocating 
their use during surgical procedure, dexamethasone 0.1 to 
1.0 mg/kg is preferred.
Body temperature control is key, and both extremes 
must be avoided – fever is known to worsen brain in-
jury secondary to ischemia or trauma, and hypothermia 
has metabolic and cardiovascular effects12. Hypothermia 
causes many important deleterious physiological conse-
quences, which increase perioperative morbidity, namely13:
t *ODSFBTFENZPDBSEJBMJTDIFNJBJOBEVMUQBUJFOUTBU
risk;
t Increased incidence of coagulation disorders and 
need for blood components transfusion;
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t Damaged cell and humoral immunity function, 
with increased risk for infections and postoperative 
hospitalization;
t Alterations in the pharmacokinetics of general an-
esthetics, extending postanesthetic distress.
Despite the fact that hypothermia reduces metabo-
lism rate and brain oxygen consumption, its use must be 
cautious in pediatrics, since children can develop severe 
hypothermia due to their larger body surface area com-
pared with adults. Just after anesthetic induction, body 
temperature undergoes an internal redistribution to pe-
ripheral compartments, followed by a stage of heat loss to 
the external environment. It is not rare for a patient to have 
hypothermia shortly after arriving at the operating room, 
and heating methods, such as warm blankets and pre-
heated crystalloid solutions infusion should be promptly 
available.
MOST FREQUENT CONDITIONS IN PEDIATRIC NEUROSURGICAL 
PATIENTS
SURGICAL CARE IN PATIENTS WITH HYDROCEPHALUS:  
VENTRICULOPERITONEAL SHUNT AND THIRD VENTRICLE ENDO-
SCOPIC VENTRICULOSTOMY
Hydrocephalus is a clinical syndrome with different defi-
nitions. It is clinically defined as an abnormal CSF ac-
cumulation in the intracranial cavity; it is radiologically 
defined as a ventricular dilatation, or increased diameter 
of both lateral ventricle temporal horns ≥ 2 mm; it is ana-
tomically defined as a lateral ventricle frontal horn extend-
ing beyond the genu of the corpus callosum14.
This syndrome may be congenital or acquired and one 
of the most commonly found conditions in neurosurgi-
cal centers across all age groups. Clinical presentation de-
pends on the age of onset and the most deleterious effects 
result from neuronal and glial cell injury due to increased 
ICP. In some cases, an emergency neurosurgical interven-
tion may be required to minimize neuronal injury.
Hydrocephalus with an early onset is significantly dif-
ferent from the adult-onset form. In adults, there are a 
few hydrocephalus causes, such as tumors, meningitides, 
and bleeding, and the site of ventricular drainage obstruc-
tion can be observed with great accuracy and represents 
a specific obstruction point15. In the pediatric age group, 
potential causes of hydrocephalus are not only related to 
the three main causes seen in adults (tumor, bleeding, 
and infection), but are also related to brain development 
abnormalities causing CSF drainage obstruction. In addi-
tion, radiological definition of these obstructions can be 
difficult16. Thus, it is often difficult to determine which ob-
struction points are the origin of the hydrocephalus, and 
the same patient can have many obstruction points, which 
makes the surgical approach of the condition much more 
difficult17.
Hydrocephalus diagnosis is based on imaging studies, 
currently head CT or MRI. However, diagnosis was for-
merly made by using ventriculography and angiography, 
and later, by transfontanelar ultrasound.
MAIN POSTOPERATIVE COMPLICATIONS
Currently, ventriculoperitoneal shunt placement, either 
by an open procedure or an endoscopic ventriculostomy, 
is the main aspect of hydrocephalus treatment. The latter 
requires higher technical ability and superior materials; 
however, it presents lower complication and morbidity 
rates due to fewer postoperative infections.
Sepsis has been reported as one of the most frequent 
and severe complications in ventriculoperitoneal shunt-
ing, with most cases arising intraoperatively. Coagulase-
negative Staphylococcus bacteria (especially Staphylococcus 
epidermidis) are frequent, but infections from Gram-neg-
ative organisms, such as Bacillus sp., can also occur. In-
fection remains the most significant early complication in 
ventriculoperitoneal shunting, with a reported incidence 
ranging from 3% to 20%, and a mean between 5% and 
10%18. Shunt-related infections not only imply longer hos-
pitalization but they can also result in severe neurologi-
cal complications, especially if the infection is caused by a 
gram-negative organism.
A widely studied practice in the United States and Eu-
rope, which is not current used in Brazil, is the antibiotic-
impregnated ventricular shunt catheters, which can be re-
lated to reduced infection rates and consequent benefits, 
as infection is the main complication resulting from ven-
triculoperitoneal shunting19.
THE CHILD WITH CRANIOSTENOSIS
The premature closure of cranial sutures results in cranio-
stenosis (or craniosynostosis) and may cause craniofacial 
dysmorphism with brain growth impairment and cogni-
tive development retardation if not appropriately treated20. 
The estimated incidence of this condition is approximately 
0.6 per 1,000 births. Syndromic craniostenoses occur 
in approximately 20% of cases and usually affect two or 
more sutures. Over 150 syndromes that can include cra-
niostenosis as part of their clinical presentation have been 
identified; Apert and Crouzon syndromes are the most fre-
quent. In these conditions, both coronal sutures are usual-
ly affected (an abnormality termed brachycephaly); in ad-
dition, patients may present with midline hypoplasia and 
obstructive sleep apnea resulting from airway anatomical 
defects21.
The main complication of operative management in 
patients with craniostenosis is coping with the inevitable 
and often significant blood losses occurring during these 
procedures. This becomes even more important if the 
fact that the majority of these surgeries are performed on 
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Glial neoplasms (astrocytomas)
Ependymomas
Primitive ectodermic tumors (medulloblastomas)
Craniopharyngiomas and pituitary tumors
Choroid plexus papilloma
Gangliogliomas
Pineal tumors
Meningiomas
Table 1 – Brain tumors more commonly found in children in 
descending order of frequency
infants is taken into account. Koh22, in a non-systematic 
review on craniostenosis surgical management, identified 
studies estimating surgery blood loss. Meyer and et al.23 
found a perioperative blood loss of 91 ± 66% of the esti-
mated blood volume. Kearney et al.24 reported a mean loss 
of 24% of the blood volume in sagittal suture repair, 21% 
for unicoronal repair, 65% for bicoronal repair, and 42% in 
metopic suture repair; indeed, blood transfusion is almost 
inevitable in craniostenosis surgery, estimated to be neces-
sary in 96.3% of cases.
THE CHILD WITH A CENTRAL NERVOUS SYSTEM TUMOR
Brain tumors in children are great surgical challenges, 
mainly because they are located in areas difficult to reach 
in the central nervous system, have large dimensions, and 
are at risk for sequelae from injury of important brain 
structures, despite the benign histological character of 
many of these lesions. On the other hand, the survival of 
children with brain tumors has significantly increased in 
the last years, with most of the patients reaching an adult 
age25. Thus, patients with neurological sequelae resulting 
from the tumor or the surgical procedure itself have higher 
morbidity over longer periods of time, including cognitive 
and psychological conditions, epilepsy, strokes, endocrine 
deficiencies (such as diabetes insipidus and panhypopitu-
itarism) or tumor relapses. The most frequent nonmeta-
static primary tumors in the central nervous system are 
listed in Table 126.
Primary brain tumors are the most common solid 
neoplasms in children, representing up to 20% of all pe-
diatric tumors26. Brain tumor incidence has increased in 
recent decades, probably due to improvement in imaging 
diagnosis methods. The estimated incidence is between 
2.76 and 4.28 per 100,000 children/year. In Brazil, few 
available data elucidate tumor incidence in children. Ar-
gollo et al.27 calculated an incidence of 1.85 per 100,000 
children/year in a cohort from the state of Bahia compris-
ing the age group from 1 to 15 years. Diagnosing brain tu-
mors in a pediatric population is challenging, with several 
visits to a pediatrician or to emergency rooms being re-
quired before the correct diagnosis is made. This is partly 
due to the low symptom specificity early in the disease 
course. Argollo et al.28, in a cross-sectional study, found 
that in up to 50% of cases the initial symptoms are only 
headache, nausea, and vomiting, and this may delay the 
diagnosis. However, advances in surgical techniques and 
adjuvant therapies have increased the survival in affected 
children, as described above.
The most frequent tumors in children are craniopha-
ryngiomas arising from squamous epithelium remnants 
of the Rathke pouch, comprising 2% to 5% of central 
nervous system tumors29. Historically, their histological 
characteristics make these tumors optimal for developing 
new surgical techniques. Morbidity resulting from radical 
tumor resection aiming to reduce relapse chances is ex-
plained by the close anatomical relationship of craniopha-
ryngiomas with the neurohypophysis and particularly the 
hypothalamus. The hypothalamic-pituitary dysfunction 
(characterized by panhypopituitarism, obesity, hyperpha-
gia, obsessive search for food, and neuropsychological 
disorders) dramatically affects the children’s and family’s 
quality of life30.
Perianesthetic complications in children with brain 
tumors may also arise from the prone position, as the 
preferential location of the tumor is the posterior cranial 
fossa, as described above31. The pins used in the surgery 
may cause skull fractures, dural fistulae, and intracranial 
hematomas. Gray matter and cranial nerve injuries may 
also occur, as well as respiratory center injuries, possibly 
causing postoperative apnea.
In Brazil, an epidemiological study conducted by 
Monteiro et al.32 in 2003 through DATASUS data analysis 
showed a 50% increase in mortality attributed to brain tu-
mors in all age groups from 1980 to 1988, with a predomi-
nance up to the age of 10 and an increased rate from 2.24 
to 3.35 per 100,000 population.
PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS IN NEUROSURGERY
Postoperative meningitis is an important cause for mor-
bidity and mortality after craniotomies. The most frequent 
infections in these procedures are surgical wound infec-
tions, followed by meningitis. Postoperative meningitis 
causes higher mortality and larger number of neurological 
sequelae compared with extradural infections. Most au-
thors cannot accurately define the antibiotic prophylaxis 
efficacy for meningitis, especially because when meningi-
tis occurs in spite of antibiotic therapy, it is usually caused 
by difficult to treat, resistant organisms.
Postoperative neurosurgical infections have high mor-
bidity rates and they are among the most severe and threat-
ening infections33. One of the seminal studies on local and 
systemic antibiotics in preventing infections used an in-
traoperative regimen of antibiotic prophylaxis consisting 
of intramuscular gentamicin or tobramycin, intravenous 
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vancomycin, and streptomycin irrigation solution, with no 
postoperative antibiotics. Total protection against postop-
erative infections was achieved in a series of 1,732 surgical 
procedures34.
In 1994, Barker et al. first collected randomized studies 
from the 1980’s in a meta-analysis, confirming intravenous 
antibiotic efficacy in reducing surgical wound infections, 
with no differences between a short regimen and extended 
use protocols35.
To date, only general recommendations for clean neu-
rosurgeries and ventriculoperitoneal shunting were re-
ported, and no consensus was reached regarding the opti-
mal antibiotic class or the optimal administration period.
In 2007, Barker et al. republished a meta-analysis 
on antibiotic prophylaxis in preventing postcraniotomy 
meningitis36. In this analysis, six controlled studies were 
reviewed, with a total of 1,729 patients. Antibiotic use re-
duced postoperative infection rates in five out of six stud-
ies. The combined odds ratio for meningitis occurrence 
after using antibiotics was 0.43 (95% CI 0.2-0.92, p = 0.03). 
Subgroup analysis did not detect differences in antibiotic 
efficacy whether gram-negative cover was used or not, 
or for single-blind or double-blind studies. This benefit 
of reducing meningitis risk by almost 50% is clinically 
significant.
Most cases presenting with postoperative fever have no 
etiological or topographical diagnosis of infection and they 
are cause for warning and exhaustive clinical and labora-
tory investigation for better understanding of the subject37.
PERIOPERATIVE ANTIEPILEPTIC DRUG PROPHYLAXIS
In general, seizure incidence in patients with supratento-
rial brain tumors reaches 40%, except in patients with low-
level astrocytomas, which may have preoperative seizures 
in up to 75% of cases38.
Considering postoperative seizure prophylaxis, phe-
nytoin is still the most used drug; however, a high inci-
dence of side effects is found, such as cytochrome P450 
enzyme induction (particularly damaging to patients re-
quiring neoadjuvant chemotherapy with hepatic metabo-
lism drugs). Similarly, carbamazepine and phenobarbi-
tal also significantly induce the enzyme system, whereas 
valproate may result in coagulation and platelet function 
disorders. Recent studies on oral or intravenous levetirace-
tam have been promising, with a high efficacy in prevent-
ing seizures and a low incidence of side effects compared 
to other antiepileptic drugs39; however, its cost and low 
availability in Brazil impair the drug use in the current 
neurosurgical setting.
The current consensus establishes that, if a neurosur-
gical patient has seizures before the procedure, antiepi-
leptic drug therapy is required. However, drug selection 
and determination of its administration period, as well as 
prophylaxis selection in patients without seizures are more 
complex issues that lack definitive recommendation40.
Seizures may cause severe consequences to the patient 
not only from neurological sequelae, but also from in-
creased brain oxygen consumption, increased ICP, brain 
hypoxia, acidosis, and traumatic injuries from falls. On the 
other hand, postoperative seizures are rare but drug side 
effects are common and include cognitive dysfunction, 
bone marrow suppression, liver failure, and reduced ac-
tion of chemotherapeutic drugs.
The concept of “mandatory” antiepileptic drugs in 
craniotomies comes from studies conducted almost 20 
years ago. In a meta-analysis selecting four randomized 
and controlled studies on phenytoin use41, a trend towards 
reduced seizures in three out of four trials was observed. 
Overall, the odds ratio for seizure occurrence was 0.42 
(0.25-0.71; p < 0.01).
These data are in contrast with the American Academy 
of Neurology recommendation, which did not indicate the 
routine use of such prophylaxis one year before42. Recent 
meta-analysis reported by the Cochrane group concluded 
there was no difference between control and intervention 
groups in preventing a first seizure in patients with brain 
tumors43. The same analysis showed patients on antiepilep-
tic drugs were six times more likely to have adverse effects, 
and these data further reduced that therapy indication. 
However, in an epidemiological study, over 70% of neu-
rosurgeons were usually found to use antiepileptic drugs 
after brain tumor surgeries44.
MANAGEMENT OF THE MAIN POSTOPERATIVE COMPLICATIONS 
IN PEDIATRIC NEUROSURGERY
HYPONATREMIA
Hyponatremia incidence depends on the patient popula-
tion in the study. Regarding inpatients, hiponatremia may 
occur in up to 20% of cases, and reach up to 50% of neu-
rosurgical patients45.
Hyponatremia is the most common electrolyte distur-
bance in patients undergoing neurosurgery. Severe hypo-
natremia may result in brain swelling and the symptoms 
reflect its effects on the central nervous system; in addi-
tion, the symptom magnitude is related to hyponatremia 
severity and the fall rate of plasma sodium levels. Initial 
symptoms may include headache, nausea, and vomiting; 
as hyponatremia worsen, mental confusion, seizures, stu-
por, and coma may develop. Studies show that in adult 
neurosurgical patients with hyponatremia, mortality is 
significantly higher and directly related to the electrolyte 
disturbance severity46.
In neurosurgical patients, hyponatremia is often at-
tributed to one of the following conditions: the syndrome 
of inappropriate antidiuretic hormone secretion (SIADH) 
or the salt-losing brain syndrome47. The former causes 
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Parameter SIADH Salt-wasting brain syndrome
Fluid balance Zero or slightly positive Negative
Urinary sodium > 20 mEq/L > 20 mEq/L
Serum albumin Normal Increased
Hematocrit Normal Increased
Potassium Low or normal High or normal
Jugular venous distention Present Absent
SIADH, syndrome of inappropriate antidiuretic hormone secretion.
Table 2 – Clinical and laboratory parameters for postoperative hyponatremia differential diagnosis in neurosurgery
hyponatremia resulting from excessive water retention, 
whereas the latter is characterized by hyponatremia, poly-
uria, and dehydration. Both are described in several neu-
rosurgical settings. Hypothalamic-pituitary axis tumors 
may course with both complications, whereas tumors out 
of that axis most commonly course with SIADH.
The differential diagnosis between the two clinical con-
ditions described above is fundamental, since treatment 
strategies are completely different in both syndromes. 
In SIADH, due to an excess ADH secretion, the patient 
should be kept in fluid restriction (including volumes ad-
ministered in medications) of approximately 70 mL/100 
kcal and, depending on volume status, loop diuretics (fu-
rosemide) and/or increased sodium supply may be pre-
scribed. In the salt-losing syndrome, volume replacement 
with an isotonic solution and increased sodium supply are 
mandatory, given the severe dehydration risk. Clinical and 
laboratory criteria for differential diagnosis can be found 
in Table 2.
DIABETES INSIPIDUS
The resection of suprasellar tumors extending to the pi-
tuitary stalk can cause loss of pituitary function and con-
sequent impairment in antidiuretic hormone secretion. 
Depending on tumor extension and type of surgical ap-
proach, the incidence of postoperative panhypopituita-
rism can reach 85% even in patients with a normal pitu-
itary function before surgery48.
Craniopharyngiomas are tumors whose main postop-
erative complication is diabetes insipidus. The absence of 
ADH secretion promotes hypernatremia due to intravas-
cular solvent loss, polyuria, and dehydration. This com-
plication onset may be seen within the first postoperative 
hours, with urine output higher than 150 mL/hour. The 
diagnosis requires suspicion raised by the type of surgical 
procedure, in addition to increasing hypernatremia occur-
rence (over 150 mEq/L), urinary sodium levels below 20 
mEq/L, plasmatic hypernatremia, and dehydration. Intra-
nasal desmopressin, an ADH synthetic analogue, should 
be replaced within the first postoperative hours to avoid 
the described metabolic complications. This medication 
can also be intravenously or orally used, but the intranasal 
route is preferred, as it makes dose titration easier, as well 
as the management of complications resulting from over-
dose, such as oliguria and dilutional hyponatremia. 
HYPERGLYCEMIA
Postoperative hyperglycemia is common due to surgical 
stress and release of insulin counter-regulatory hormones, 
such as catecholamines, glucagon, and cortisol. Several 
studies recognize the importance of hyperglycemia in pe-
diatric intensive therapy, increasing the patients’ morbidi-
ty and mortality during hospitalization. In a neurosurgical 
setting, hyperglycemia is poorly studied. In a retrospective 
cohort study, Mekitarian Filho et al.49 found a hyperglyce-
mia incidence of 62.6% in 198 children undergoing several 
neurosurgical procedures; however, multiple analysis did 
not show an association between hyperglycemia and lon-
ger length of hospitalization or stay in intensive care units, 
or mechanical pulmonary ventilation.
FEVER OF UNKNOWN ORIGIN
As described above, the finding of fever, mainly within 
the first 48 hours of the surgical procedure, is very com-
mon and has been the subject of extended and costly in-
vestigations.  The consensus is that a complete work-up, 
including a complete blood count, inflammatory activ-
ity assays (CRP and procalcitonin), and cultures, includ-
ing urine mycological analysis and fungal culture, should 
be obtained after a 48-hour fever or if the patient shows 
worsening of clinical status with sepsis signs and/or sep-
tic shock in the presence of previous mandatory antibiotic 
prophylaxis.
BRAIN EDEMA AND TRANSIENT NEUROLOGICAL FOCAL DEFICIT
Surgical handling of any area of the central nervous system 
may cause perilesional edema in several grades, impacting 
the postoperative clinical symptomatology. Postoperative 
systemic corticosteroid use is usual in pediatric neurosur-
gery aiming to reduce complications; however, there is no 
evidence warranting a benefit from the use of these drugs. 
Corticosteroid adverse effects, such as hyperglycemia, in-
fection, and slow wound healing are well known, but the 
role of costicosteroid use on complications is unclear.
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Similarly, little is known about the incidence of neu-
rological focal deficits in several types of neurosurgery 
in children; according to large case studies, the incidence 
ranges from 5% to 15%7. In certain surgeries, such as 
meningioma resection and spine surgical manipulation, 
deficits may be more common. Hamilton et al.50 found ap-
proximately 1% of deficits related to nervous compression 
or cauda equina syndrome in 108,419 spine procedures 
in a retrospective study. In supratentorial tumors, such as 
gliomas and meningiomas, the findings show a new deficit 
development in 6.8% to 29% of cases51,52, with a multiple 
analysis conducted on 57 adults with meningiomas show-
ing that the only factor associated with increased morbid-
ity and mortality was the aforementioned deficit.
CONCLUSION
Recognizing the complications in pediatric neurosurgery 
is fundamental for appropriate patient management dur-
ing the early postoperative period. The three most com-
mon procedures in children are craniostenosis correction, 
hydrocephalus and ventriculoperitoneal shunting and 
brain tumor resection, each of them with their most com-
mon complications. Bleeding, infection, and sodium dis-
turbances are the more frequently reported complications. 
Elective neurosurgeries are potentially contaminated pro-
cedures in which cephalosporins, especially second-gen-
eration cephalosporins, should be used as prophylaxis for 
48 to 72 hours. Antiepileptic drugs are mandatory in early 
postoperative prescriptions if the patient has had seizures 
before the procedure.
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